PCI Biotech Holding ASA engages in the research and development of biopharmaceutical products for cancer treatment. Its photochemical internalization technology therapy enhances the effect of anticancer drugs on the body. The company was founded in 2000 and is headquartered in Oslo, Norway.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company